Ashley M Jacobi

4PUBLICATIONS
28CO-AUTHORS
Software quality, processes and metricsSeparation technologiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Aug 11, 2026
UNCOVERseq enables sensitive and controlled gene editing off-target nomination across CRISPR-Cas modalities and systems.

|Feb 22, 2023
A versatile, high-efficiency platform for CRISPR-based gene activation.

Amy J Heidersbach, Kristel M Dorighi, Javier A Gomez

|Nov 19, 2020
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy.

Daniel Rosenblum, Anna Gutkin, Ranit Kedmi

|Aug 08, 2018
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells.

Christopher A Vakulskas, Daniel P Dever, Garrett R Rettig

Pageof 1

Frequent Collaborators

3 joint publications

Mark Behlke

2 joint publications

Rolf Turk

2 joint publications

Garrett Rettig

1 joint publications

Kyle J Kinney

1 joint publications

Ellen Schmaljohn

1 joint publications

Thomas Osborne

1 joint publications

Karthik Murugan

1 joint publications

Andrea Sánchez-Peña

1 joint publications

Morgan Sturgeon

1 joint publications

Matthew S McNeill

Frequent Collaborators

3 joint publications

Mark Behlke

2 joint publications

Rolf Turk

2 joint publications

Garrett Rettig

1 joint publications

Kyle J Kinney

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us